R. Investigators

Inadequate anticoagulant therapy during end of study transition to open-label vitamin K antagonist therapy: experience in ROCKET AF

R. Investigators, 2012 .

Rationale and design of the ROCKET AF study: comparison of rivaroxaban with warfarin for the prevention of stroke and systemic embolism in patients with atrial fibrillation

R. Investigators, 2009 .

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.

R. Investigators, 2010, American heart journal.

Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.

R. Investigators, 2010, American heart journal.

Abstract 2015: Survival from Out-of-Hospital Cardiac Arrest is Better for Children than Adults: The ROC Epistry-Cardiac Arrest

D. Davis, R. Berg, D. Atkins, 2007 .